UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042763
Receipt number R000048812
Scientific Title Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase
Date of disclosure of the study information 2020/12/16
Last modified on 2020/12/16 00:50:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase

Acronym

Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase

Scientific Title

Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase

Scientific Title:Acronym

Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase

Region

Japan


Condition

Condition

Kawasaki Disease

Classification by specialty

Cardiology Pediatrics Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of the present study was to compare the outcomes of KD children treated with high-Na and low-Na IVIG preparations using a national inpatient database in Japan.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Coronary artery abnormalities

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

High Na IVIG

Interventions/Control_2

Low Na IVIG

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

6 years-old >=

Gender

Male and Female

Key inclusion criteria

We used the Diagnostic Procedure Combination database to identify KD patients treated with IVIG between 2010 and 2017 and further identified those receiving high-Na and low-Na IVIG preparations as their initial treatment. The study outcomes included proportion of CAAs, proportion of IVIG resistance, length of stay, and medical cost. Propensity score-matched analyses were conducted to compare the outcomes between the two groups. Instrumental variable analyses were performed to confirm the results.

Key exclusion criteria

exclude patients with a suspected diagnosis of KD, inadequate treatment, and age over 6 years.

Target sample size

42345


Research contact person

Name of lead principal investigator

1st name Nobuaki
Middle name
Last name Michihata

Organization

The University of Tokyo

Division name

Department of Health Services Research, Graduate School of Medicine

Zip code

113-0033

Address

7-3-1 Hongo, Bunkyo-ku

TEL

0358411887

Email

gha10771@gmail.com


Public contact

Name of contact person

1st name Nobuaki
Middle name
Last name Michihata

Organization

The University of Tokyo

Division name

Department of Health Services Research, Graduate School of Medicine

Zip code

113-0033

Address

7-3-1 Hongo, Bunkyo-ku

TEL

0358411887

Homepage URL


Email

gha10771@gmail.com


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

The University of Tokyo

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The University of Tokyo

Address

7-3-1 Hongo, Bunkyo-ku

Tel

+81358411887

Email

gha10771@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 16 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

42345

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 12 Month 16 Day

Date of IRB

2017 Year 12 Month 25 Day

Anticipated trial start date

2020 Year 12 Month 16 Day

Last follow-up date

2020 Year 12 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 12 Month 16 Day

Last modified on

2020 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048812


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name